Stock comparison

LLYvsTSLA

Eli Lilly and Co vs Tesla Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

TSLA

Tesla Inc

$400.62

-15.69%

Automobiles$1.45TNASDAQ

60-day price, rebased to 100

LLY -12.77% · TSLA -6.92%

Round-by-round

LLY 1·TSLA 4· 1 tie

Tie

Valuation upside

-92.70% vs -92.30% to DCF fair value

EdgeTSLA

Balance-sheet strength

Altman Z 15.74 vs 33.68

EdgeLLY

Fundamental quality

Piotroski 6.00 vs 4.00 (of 9)

EdgeTSLA

Growth + margins

Rule-of-40 -9.10 vs 18.90

EdgeTSLA

60-day momentum

-12.77% vs -6.92% price return

EdgeTSLA

Market-cap liquidity

$884.0B vs $1.45T

Verdict

Across 6 categories, TSLA takes the edge with 4 wins to 1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on LLY or TSLA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.